FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Adynxx's Free Cash Flow for the
three
months ended in Sep. 2019 was $-0.54 Mil. Adynxx's Revenue for the
three
months ended in Sep. 2019 was $0.00 Mil. Therefore, Adynxx's FCF Margin % for the quarter that ended in Sep. 2019 was 0.00%.
The historical rank and industry rank for Adynxx's FCF Margin % or its related term are showing as below:
ADYX'
s FCF Margin % Range Over the Past 10 Years
Min: -1170.29 Med: 0 Max: 0
Current: -1170.29
ADYX's FCF Margin % is not ranked
in the Biotechnology industry.
Industry Median: -147.18
vs ADYX: -1170.29
Adynxx FCF Margin % Historical Data
The historical data trend for Adynxx's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Adynxx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adynxx's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Adynxx's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Adynxx's FCF Margin % falls into.
Adynxx FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Adynxx's FCF Margin for the fiscal year that ended in Dec. 2018 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adynxx FCF Margin % Related Terms
Thank you for viewing the detailed overview of Adynxx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ADYX has been successfully added to your 